| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/10/2011 | CA2771410A1 Methods for improving recombinant protein expression |
| 02/10/2011 | CA2770412A1 Method of efficiently establishing induced pluripotent stem cells |
| 02/10/2011 | CA2770130A1 Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease |
| 02/10/2011 | CA2769665A1 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 02/10/2011 | CA2769610A1 Immunogenic composition comprising antigenic s. aureus proteins |
| 02/10/2011 | CA2769464A1 Humanized anti-amyloid-.beta. oligomer antibody |
| 02/10/2011 | CA2769333A1 Enterococcus and fecal bacteroides for rapid water quality assessment |
| 02/10/2011 | CA2769262A1 Methods and compositions for treating trinucleotide repeat disorders |
| 02/10/2011 | CA2769219A1 Process and device for collecting nucleic acids of microorganisms from a particulate sample |
| 02/10/2011 | CA2769001A1 Novel proteins |
| 02/10/2011 | CA2768990A1 Broad spectrum erbb ligand binding molecules and methods for preparing and using them |
| 02/10/2011 | CA2768428A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biormass, oil content, and/or nitrogen useefficiency of plants |
| 02/09/2011 | EP2282208A1 Methods and compounds for the diagnosis and treatment of cancer |
| 02/09/2011 | EP2281903A1 Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent |
| 02/09/2011 | EP2281897A2 Oncolytic mutant Herpes Simplex virus |
| 02/09/2011 | EP2281896A2 Transgenic plant-based methods for plant insect pests using RNAi |
| 02/09/2011 | EP2281895A2 Methods for enhancing stress tolerance in plants and compositions thereof |
| 02/09/2011 | EP2281894A2 Protein kinase stress-related proteins and methods of use in plants |
| 02/09/2011 | EP2281893A1 System for the expression of peptides on the bacterial surface |
| 02/09/2011 | EP2281892A2 Methods for producing polypeptides in respiratory-deficient Trichoderma cells |
| 02/09/2011 | EP2281891A2 Streptococcus antigens |
| 02/09/2011 | EP2281890A1 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms |
| 02/09/2011 | EP2281889A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 02/09/2011 | EP2281888A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 02/09/2011 | EP2281887A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 02/09/2011 | EP2281886A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 02/09/2011 | EP2281885A1 Combination therapy for the treatment of ocular neovascular disorders |
| 02/09/2011 | EP2281884A1 Mesothelioma-specific promoter and use thereof |
| 02/09/2011 | EP2281883A1 Method for determination of dna methylation |
| 02/09/2011 | EP2281880A2 Mutant microorganism with high ability of producing putrescine and preparation of putrescine using same |
| 02/09/2011 | EP2281879A1 Method and apparatus for selectively targeting specific cells within a cell population |
| 02/09/2011 | EP2281877A2 Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| 02/09/2011 | EP2281869A2 Modulation of diacylglycerol acyltransferase 1 expression |
| 02/09/2011 | EP2281845A1 Stable polyvalent antibody |
| 02/09/2011 | EP2281843A1 Antibodies that immunospecifically bind to blys |
| 02/09/2011 | EP2281842A1 Antibodies that immunospecifically bind to BLyS |
| 02/09/2011 | EP2281840A2 Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 02/09/2011 | EP2281838A1 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 02/09/2011 | EP2281837A2 Antigen binding domains from fish |
| 02/09/2011 | EP2281836A1 Hybrid proteins from Parietaria judaica major allergens and uses thereof |
| 02/09/2011 | EP2281835A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281834A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281833A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281832A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/09/2011 | EP2281826A1 Reagents, chaotropic agents, kits and methods for isolating nucleic acids based on magnetic cellulose materials |
| 02/09/2011 | EP2281572A1 West Nile Vaccine |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2281447A2 Corn event MIR604 |
| 02/09/2011 | EP2281051A1 Desaturase and method for the production of polyunsaturated fatty acids in transgenic organisms |
| 02/09/2011 | EP2281050A1 Linear donor constructs for targeted integration |
| 02/09/2011 | EP2281049A2 Compositions and methods for the suppression of target polynucleotides from the family aphididae |
| 02/09/2011 | EP2281048A1 Genetically modified eukaryotic cells |
| 02/09/2011 | EP2281047A1 Methods to produce rod-derived cone viability factor (rdcvf) |
| 02/09/2011 | EP2281046A2 LUCIFERASE BIOSENSORS FOR cAMP |
| 02/09/2011 | EP2281045A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 02/09/2011 | EP2281044A1 Oligonucleotides for inhibiting and for identifying human argonaute proteins |
| 02/09/2011 | EP2281043A2 Improved tlr3 agonist compositions |
| 02/09/2011 | EP2281042A1 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 02/09/2011 | EP2281041A2 Silencing of csn5 gene expression using interfering rna |
| 02/09/2011 | EP2281040A2 Lyophilized dna formulations for enhanced expression of plasmid dna |
| 02/09/2011 | EP2281035A2 Production of nucleic acid |
| 02/09/2011 | EP2281011A2 Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
| 02/09/2011 | EP2281007A2 Anti-atheroma vaccine |
| 02/09/2011 | EP2281003A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 02/09/2011 | EP2281002A2 Anti-alk1 antibodies and uses thereof |
| 02/09/2011 | EP2085475B1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
| 02/09/2011 | EP1970380B1 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof |
| 02/09/2011 | EP1907544B1 Membrane-translocating peptides |
| 02/09/2011 | EP1885754B1 T cell receptors which specifically bind to vygfvracl-hla-a24 |
| 02/09/2011 | EP1874808B1 Catalase gene and use thereof |
| 02/09/2011 | EP1725659B1 Natural igm antibodies and inhibitors thereof |
| 02/09/2011 | EP1716869B1 Drug for preventing or treating heart diseases comprising cd9 gene |
| 02/09/2011 | EP1702987B1 Method of constructing yellow flower by regulating flavonoid synthesis system |
| 02/09/2011 | EP1699936B1 Universal amplification of fragmented rna |
| 02/09/2011 | EP1680502B1 Recombinant microorganism |
| 02/09/2011 | EP1648931B1 Multifunctional cytokines |
| 02/09/2011 | EP1636561B1 Combinatorial protein library screening by periplasmic expression |
| 02/09/2011 | EP1594972B1 Transposon-based targeting system |
| 02/09/2011 | EP1577390B1 Human cancer-related genes, the products encoded thereby and applications thereof |
| 02/09/2011 | EP1572027B1 Implants coated with Aptamere which mediate the adhesion of endothelial progenitor cells |
| 02/09/2011 | EP1504098B2 A method for in vitro molecular evolution of protein function |
| 02/09/2011 | EP1311680B1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
| 02/09/2011 | EP1280898B1 Modified es cells and es cell-specific gene |
| 02/09/2011 | EP1181313B1 Peptides for vaccinating against human cmv |
| 02/09/2011 | EP1100929B1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
| 02/09/2011 | EP0986577B1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/09/2011 | EP0848755B2 Vegf-related protein |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN1922326B 2-micron family plasmid and use thereof |
| 02/09/2011 | CN1859926B Polymer encapsulation of adenoviruses |
| 02/09/2011 | CN1839151B Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs |
| 02/09/2011 | CN101970691A A human non-antibody peptide or protein phage library |
| 02/09/2011 | CN101970678A Biological active proteins having increased in vivo and/or vitro stability |
| 02/09/2011 | CN101970673A Butanol production in a eukaryotic cell |
| 02/09/2011 | CN101970671A Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate |
| 02/09/2011 | CN101970670A Methods for inhibiting angiogenesis using egfl8 antagonists |
| 02/09/2011 | CN101970669A Gray leaf spot tolerant maize and methods of production |
| 02/09/2011 | CN101970668A Plants with modified starch metabolism |
| 02/09/2011 | CN101970667A Brassica plant comprising a mutant indehiscent allele |
| 02/09/2011 | CN101970666A Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |